| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| H9LMD8 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| E9L8H9 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| W4VSQ7 | Arylformamidase, isoform CRA_b; Kynurenine formamidase; | AFMID; | NULL | 57 | human |
| Q8WTS0 | Nav1.5; Fragment; | SCN5A; | NULL | 156 | human |
| G9LM25 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| H3BMD8 | cAMP-regulated phosphoprotein 19; | ARPP19; | XP_005254189.1;XP_005254190.1;XP_005254191.1; | 131 | human |
| D6C3F8 | Cytochrome b; | CYTB; | NULL | 380 | human |
| A6YZM0 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| A0S9B7 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| M0QZI7 | Zinc finger protein 160; Zinc finger protein 160, isoform CRA_b; | ZNF160; | XP_005259436.1; | 782 | human |
| D7P639 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 601 | human |
| H0YLJ1 | Probable phospholipid-transporting ATPase IM; | ATP8B4; | NULL | 122 | human |
| E9PLS8 | Centrosomal protein of 164 kDa; Fragment; | CEP164; | NULL | 121 | human |
| I7FC38 | Sterile alpha motif domain containing 11 splice variant ASV17; Sterile alpha motif domain containing 11 splice variant ASV18; | SAMD11; | NULL | 572 | human |
| Q6EWN4 | Neuronal nicotinic acetylcholine receptor, alpha5 subunit; Fragment; | CHRNA5; | NP_000736.2; | 57 | human |
| A6YWD1 | Cytochrome c oxidase subunit 2; | COX2; | NULL | 227 | human |
| Q6L9M1 | Peroxisome proliferator-activated receptor; Peroxisome proliferator-activated receptor gamma 1; Fragment; | PPARG; | NULL | 41 | human |
| Q85KT3 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| D6W5P7 | ADAM metallopeptidase domain 22, isoform CRA_a; | ADAM22; | NULL | 761 | human |
| Q9B300 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |